SELICK HAROLD E
SEC Form 4 insider trading activity
SELICK HAROLD E has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Mar 27, 2026.
On the most recent filing, SELICK HAROLD E is listed as Director at Protagonist Therapeutics, Inc. Inside the rolling window, SELICK HAROLD E reported no open-market purchases and 1 open-market sale totaling $2.5M in PTGX.
Companies traded
Other insiders at PTGX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has SELICK HAROLD E made?
SELICK HAROLD E has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does SELICK HAROLD E trade?
SELICK HAROLD E has filed SEC Form 4 disclosures for 1 company, including PTGX.
When was SELICK HAROLD E's most recent SEC Form 4 filing?
SELICK HAROLD E's most recent SEC Form 4 filing on Tracefour is dated Mar 27, 2026.
What is SELICK HAROLD E's total buy and sell value in the current window?
Inside the rolling retention window, SELICK HAROLD E bought $0 and sold $2.5M based on SEC Form 4 filings.
What was SELICK HAROLD E's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 24,000 PTGX shares on 2026-03-26, worth $2.5M, per SEC Form 4 filings.